Blood samples from people participating in a COVID-19 vaccine study are processed at the Ndlovu Care Group in Elandsdoorn, 200 kms north-east of Johannesburg Thursday Feb. 11, 2021. the Ndlovu group is running a study of the Johnson & Johnson vaccine with 602 people from the community participating.
